Aurobindo Pharma Ltd
Aurobindo Pharma Ltd - 524804 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
01 / The disclosure
What the company shared
Intimation of completion of acquisition.
A question for your research
Check transaction size, funding, dilution, approvals and completion conditions before assessing the earnings impact.
Numbers found in document text 1 matches
Automatic text matches, not verified financial metrics. A match may come from a table heading or reporting year. Expand it to inspect the surrounding text and original page.
100%Page 1
Further, A1 Labs India, through its wholly owned subsidiary A1 Biochem USA Inc, USA, has acquired 100% membership interest of A1 Biochem Labs LLC, USA (step-down subsidiary of A1 Labs India) which is operating in USA.
View source pageThe evidence
Read the source excerpts
01We refer to our letters dated July 23, 2026 and September 12, 2026, October 01, 2026, and October 02, 2026 informing that Apitoria Pharma Private Limited ("Apitoria"), a wholly owned subsidiary of the Company , is acquiring the Contract Research Services business of A1 Biochem Group.
Page 1
02In continuation to the above and in compliance with Regulation 30 and other applicable provisions of the SEBI LODR Regulations, this is to inform that post the completion of the conditions p rescribed under the definitive agreements, the acquisition of the business of A1 Biochem Group has been completed.
Page 1
03Further, A1 Labs India, through its wholly owned subsidiary A1 Biochem USA Inc, USA, has acquired 100% membership interest of A1 Biochem Labs LLC, USA (step-down subsidiary of A1 Labs India) which is operating in USA.
Page 1
04Through this acquisition, Apitoria now has access to an existing CRO platform with 50+ client base and experience of com pleting 800+ projects in India and USA.
Page 1
05This acquisition complements Apitoria’s manufacturing capabilities to create an integrated CRDMO platform and expand the portfolio of offerings to the customers and longer life cycle engagement with the customers.
Page 1
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 2111423d-037d-4ecb-8796-90cc03288cfc
- First collected
- 3 Oct 2026, 17:18 IST
- PDF extraction
- extracted · 1 pages read
- Extraction note
- Source excerpts; financial tables have not been validated.
- Document SHA-256
- 53e80d6927e86315545e8a92c384318d4cc1bf01f135231f76018503a40ac41e